Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: J Clin Oncol. 2006 Oct 1;24(28):4603–4610. doi: 10.1200/JCO.2005.04.5518

Table 4.

Biomarkers Versus Imaging/Size

MRI
Classification
Distribution Enhancement No. of
Patients
Ki67
(%)
CD68
(No.)
CD34
(No.)
ER
Score
MRI Size
(mm)
Pathologic
Size
(mm)
Pathologic
Density
Score
Group 1 Focal All 8
 Mean 22.3 24.8 67 3.5 22.1 15.4 1.8
 SD 18 11.3 35.6 3.3 24.1 4 0.7
 Range 5.3–55.2 8–45 27–140 0–8 4–77 9–20 1–3
Group 2 Linear ductal All 7
 Mean 38.9 29 80.3 3.5 26.9 34.9 1.3
 SD 18 7.6 77.2 3 19.2 47.2 0.5
 Range 17.2–71 20–42 15–198 0–8 9–60 9–140 1–2
Group 3 Segmental, regional, multiregional Heterogeneous 12
 Mean 24.1 29 69 4.4 49.3 21.9 1.7
 SD 16.2 16.3 35.4 2.5 25.1 16.3 0.8
 Range 0.9–53 13–73 21–122 0–8 18–93 4–50 1–3
Group 4 Regional, multiregional Clumped 8
 Mean 26.3 62.8 50.8 2.1 71.6 41.9 2.3
 SD 11.9 49.5 28.5 3 40.1 31.8 0.5
 Range 8.1–43.2 20–145 28–117 0–7 36–158 14–90 2–3
Group 5 Segmental Clumped 7
 Mean 30.5 63.5 64.9 3.4 56.6 43.7 2.9
 SD 13.6 51.9 22.6 3.3 9.5 12.8 0.4
 Range 15.4–47.6 14–166 17–87 0–7 40–70 24–60 2–3
Group 6 Segmental, regional, multiregional Homogeneous 3
 Mean 29.4 99.7 70 1 71.7 53 2.3
 SD 14.5 61.2 12.5 1.7 47.6 35.6 0.6
 Range 14.5–43.4 34–155 60–84 0–3 21–114 19–90 2–3

Abbreviations: MRI, magnetic resonance imaging; ER, estrogen receptor; SD, standard deviation.